Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-16

Clinical Trial Update: A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating the safety of TRK-950 in patients with advanced solid tumors. The study included colon cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRK-950

Snippet

Sponsor: Toray Industries, Inc | Conditions: Locally Advanced or Metastatic Solid Carcinomas, Colon Cancer | Phase 1 | Status: COMPLETED